Algorithm379 is a preclinical-stage biopharmaceutical company discovering and developing innovative therapeutics for the immune and metabolic diseases. Our major focus is RNA and protein based therapeutics as well as novel drug formulations for small molecules.
We are also exploring how the repurposing of the existing drugs can help deliver better precision medicine solutions to the patients.
The paradigm shift in drug discovery and therapeutics development requires the combination of cheminformatics, bioinformatics and advanced -omics based data analytics. Thus, we employ computational biology advances to help our clients with their R&D challenges by offering bespoke solutions.
Our tailor-made solutions using the state-of-the-art AI/ML discoveries speed up target identification and therapeutics screens. By integrating public, proprietary and client data we can uncover the real therapeutic potential.
Company Details
- Founded
- -
- Address
- Vilnius, Lt
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Drug discovery, Bioinformatics, Cheminformatics, Proteomics, In silico therapeutics, Patient data modelling, Big data, AI, Machine learning, Metabolic diseases, Immune diseases, Biologics, PROTACS, Protein engineering, CRO, Collaborative research, Pathways.
- HQ
- Vilnius
Algorithm379 Questions
Algorithm379's website is http://algorithm379.com/ALGORITHM379/
Algorithm379's LinkedIn profile is https://lt.linkedin.com/company/algorithm379
Algorithm379's industry is
Biotechnology Research
Algorithm379's top competitors are
Neurotechnology,
Algorithm360,
Artificial Intelligence Association Of Lithuania,
Brain And Ai Research Group,
Cloudatlas,
Ami Tech,
Bharatiya Janata Party (Bjp),
Moterra,
Algorithms365,
Oxus.ai.
Algorithm379's categories are Biotechnology Research
Algorithm379's founding year is 2021
